Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For the first time in 29 years, the industry's most...
Simcere Pharma has filed an Investigational New Drug...
It's earnings season, and almost every day for the past...
Epitomics, the San Francisco-area biopharma with two...
Simcere Pharma was given SFDA approval to begin China...
PW Medtech Group of China paid $130 million to acquire...
GlaxoSmithKline will pay a $489 million fine to settle...
Innovent Biologics of Suzhou expanded its 10-year...
Hutchison China MediTech (Chi-Med) will raise $100...
Sorrento Therapeutics, a San Diego-China biopharma,...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
